Cargando…
Microglia Mediated Neuroinflammation in Parkinson’s Disease
Parkinson’s Disease (PD) is the second most common neurodegenerative disorder seen, especially in the elderly. Tremor, shaking, movement problems, and difficulty with balance and coordination are among the hallmarks, and dopaminergic neuronal loss in substantia nigra pars compacta of the brain and a...
Autores principales: | Isik, Sevim, Yeman Kiyak, Bercem, Akbayir, Rumeysa, Seyhali, Rama, Arpaci, Tahire |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10093562/ https://www.ncbi.nlm.nih.gov/pubmed/37048085 http://dx.doi.org/10.3390/cells12071012 |
Ejemplares similares
-
The Contribution of Microglia to Neuroinflammation in Parkinson’s Disease
por: Badanjak, Katja, et al.
Publicado: (2021) -
Microglia and Astrocytes Dysfunction and Key Neuroinflammation-Based Biomarkers in Parkinson’s Disease
por: Chen, Kun, et al.
Publicado: (2023) -
Contribution of Microglia-Mediated Neuroinflammation to Retinal Degenerative Diseases
por: Madeira, Maria H., et al.
Publicado: (2015) -
Microglia-Mediated Neuroinflammation: A Potential Target for the Treatment of Cardiovascular Diseases
por: Wang, Menglong, et al.
Publicado: (2022) -
Microglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson’s Disease-Lessons from Transgenic Mice
por: Machado, Venissa, et al.
Publicado: (2016)